Literature DB >> 2019750

Direct time-resolved fluorescence immunoassay for serum oestradiol based on the idiotypic anti-idiotypic approach.

A Altamirano-Bustamante1, G Barnard, F Kohen.   

Abstract

We report a novel competitive type immunoassay for oestradiol based on the idiotypic anti-idiotypic approach. This has been achieved by the production of an anti-idiotypic antibody (anti-Id) which is directed against the oestradiol binding site of the primary idiotypic antibody (Ab1). In this format the primary Ab1 was captured onto the surface of microtitre wells and oestradiol standards or serum samples were then allowed to compete with europium labelled anti-Id for the binding sites of Ab1. Fluorescence was proportional to the concentration of oestradiol over the range 0-8 ng/ml. The sensitivity of the assay was 80 +/- 20 pg/ml, whilst the intra-assay variation ranged from 3 to 10%, and the inter-assay variation from 7.3 to 15%. The results obtained by the fluorescence immunoassay correlated well with those obtained by an extraction radioimmunoassay using tritiated antigen and dextran-coated charcoal for separation of bound and free ligand (n = 60, r = 0.98). The idiotypic anti-idiotypic approach in hapten immunoassays enables antibodies to be labelled instead of haptens, and thus permits the development of robust and sensitive immunoassays.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2019750     DOI: 10.1016/0022-1759(91)90068-q

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  2 in total

1.  Temporally and spectrally resolved imaging microscopy of lanthanide chelates.

Authors:  G Vereb; E Jares-Erijman; P R Selvin; T M Jovin
Journal:  Biophys J       Date:  1998-05       Impact factor: 4.033

2.  Anti-idiotypic immunization provides protection against lethal endotoxaemia in BALB/c mice.

Authors:  J J Cornelissen; K Maassen; L van Emst; P M Weers; M Harmsen; B J Benaissa-Trouw; T A Oosterlaken; C A Kraaijeveld; J Verhoef
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.